**Author details**

Marina Comisso1 \*, Andrea Montalto1 , Francesca Nicolò1 , Romina Pantanella2 and Francesco Musumeci1

1 Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy

2 Department of Cardiac Surgery, Sant Andrea Hospital, Rome, Italy

\*Address all correspondence to: marina.comisso@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**11**

*Minimally Invasive Ventricular Assist Device Surgery DOI: http://dx.doi.org/10.5772/intechopen.90911*

> device in patient with left ventricular non-compaction. Journal of Cardiac Surgery. Feb 2017;**32**(2):159-161

[10] Belhaj A. Actual knowledge of systemic inflammation reaction during cardiopulmonary bypass. Recent Patents on Cardiovascular Drug Discovery.

[11] Cheung A, Lamarche Y, Kaan A, et al. Off-pump implantation of the HeartWare HVAD left ventricular assist device through minimally invasive incision. The Annals of Thoracic Surgery. 2011;**91**:1294-1296

[12] Cheng A. Minimally invasive left ventricular assist device placement. Journal of Visceral Surgery. 2015;**1**:25

[13] Pagani FD, Miller LW, Russel SD, et al. Extended mechanical circulatory support with continuous-flow rotary left ventricular assist device. Journal of the American College of Cardiology.

[14] Wiedemann D, Haberl T, et al. Minimally invasive approaches for implantation of left ventricular assist device. Indian Journal of Thoracic and Cardiovascular Surgery.

2018;**34**(Suppl 2):S177-S182

[15] Centofanti P, La Torre M,

[16] Maltais S, Davis ME,

Surgery. 2014;**3**:563-569

Attisani M, et al. Rapid pacing for the off-pump insertion of the Jarvik left ventricular assist device. The Annals of Thoracic Surgery. 2011;**92**:1536-1538

Haglund N. Minimally invasive and alternative approaches for long term LVAD placement: The Vanderbilt strategy. Annals of Cardiothoracic

[17] Galiè N, Ussia G, Passarelli P, et al. Role of pharmacologic tests in the treatment of primary pulmonary

2012;**7**:165-169

2009;**54**:312-321

**References**

[1] Nair AP, Timoh T, Fuster V. Contemporary medical management of systolic heart failure. Circulation

Journal. 2012;**76**:268-277

[2] Lund LH, Edwards LB,

Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report–2015; focus theme: Early graft failure. The Journal of Heart and Lung Transplantation. 2015;**34**:1244-1254

[3] Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15000 patients and counting. The Journal of Heart and Lung Transplantation. 2015;**34**:1495-1504

John R, et al. Pump replacement for left ventricular assist device failure can be done safety and is associated with low mortality. The Annals of Thoracic

[5] Coyle LA, Ising MS, Gallagher C, et al. Destination therapy: One year outcome in patients with a body mass index greater than 30. Artificial Organs.

[6] Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular device. The New England Journal of Medicine. 3 Dec 2009;**361**(23):2241-2251

[7] Hanke JS, Rojas SV, Avsar M, et al. Minimally-invasive LVAD implantation: State of the art. Current Cardiology

[8] Ponikowski P, Voor AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2016;**18**:891-975

[9] Balsara KR, Bierhals A, Vader J, et al. Implantation of left ventricular assist

Reviews. 2015;**11**:246-251

[4] Moazami N, Milano CA,

Surgery. 2013;**95**:500-505

2010;**34**:93-97

*Minimally Invasive Ventricular Assist Device Surgery DOI: http://dx.doi.org/10.5772/intechopen.90911*
